The Lowy Institute for International Policy held a seminar during May that discussed the ramifications of Thailand’s move “to issue a compulsary license for a patented heart drug”. The resulting outcomes report will be of interest to the many New Mandala readers who are following the controversy around Thailand’s recent health policy decisions.